Within a modern study, we reported the identification and also the characterization of a new atypical opioid receptor with one of a kind detrimental regulatory Houses toward opioid peptides.1 Our benefits showed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is additionally a wide-spec